Showing results (291-300 of 315) with videos related to

Sort By:
Pageof 32
Diabetologia|July 2, 2026
GIP contributes to postprandial regulation of splanchnic blood supply in humans with type 2 diabetes: a randomised, single-blinded, placebo-controlled, crossover studyRasmus S Rasmussen, Sophie W Nielsen, Lotte Alstrup, et al.
Lancet (London, England)|May 3, 2026
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trialMette Kruse Klausen, Signe Keller Justesen, Julie Niemann Pedersen, et al.
Diabetes|December 17, 2015
Evidence of Extrapancreatic Glucagon Secretion in ManAsger Lund, Jonatan I Bagger, Nicolai J Wewer Albrechtsen, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2023
Altered Glucagon and GLP-1 Responses to Oral Glucose in Children and Adolescents With Obesity and Insulin ResistanceSara Elizabeth Stinson, Ierai Fernández de Retana Alzola, Emilie Damgaard Brünner Hovendal, et al.
Diabetes|July 25, 2024
Glucagon Clearance Is Decreased in Chronic Kidney Disease but Preserved in Liver CirrhosisMagnus F G Grøndahl, Andreas H Lange, Malte P Suppli, et al.
British Journal of Pharmacology|July 2, 2024
Altered desensitization and internalization patterns of rodent versus human glucose-dependent insulinotropic polypeptide (GIP) receptors. An important drug discovery challengeLærke Smidt Gasbjerg, Rasmus Syberg Rasmussen, Adrian Dragan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 11, 2020
Enteroendocrine K Cells Exert Complementary Effects to Control Bone Quality and Mass in MiceBenoît Gobron, Béatrice Bouvard, Sagar Vyavahare, et al.
Cell Chemical Biology|July 8, 2026
GLP-1R and GIPR crosstalk modulates insulinotropic signaling pathwaysPeter Lindquist, Luuk R H Dijkhof, Anna K Drzazga, et al.
Frontiers in Microbiology|June 28, 2021
Effect of Fecal Microbiota Transplantation Combined With Mediterranean Diet on Insulin Sensitivity in Subjects With Metabolic SyndromeAnnefleur M Koopen, Eduardo L Almeida, Ilias Attaye, et al.
JAMA Psychiatry|December 3, 2025
Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders: A Randomized Clinical TrialMarie R Sass, Mette Kruse Klausen, Christine R Schwarz, et al.
Pageof 32